MedPath

MRI-based 3D Hip Labrum and Cartilage Morphology in Patients With Hip Deformities Compared to Asymptomatic Volunteers

Recruiting
Conditions
Hip Disease
Interventions
Other: Magnetic Resonance Imaging (MRI) of the hip with intra-articular contrast agent
Other: Non- contrast Magnetic Resonance Imaging (MRI) of the hip
Registration Number
NCT06095219
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Brief Summary

In this study, the investigators seek to describe the normal 3D hip joint morphology in asymptomatic volunteers and compare it to various hip joint deformities. Asymptomatic volunteers will be asked to undergo a non-contrast MRI of the hip at 3 Tesla, utilizing a high-resolution morphologic 3D sequence (3D T2 DESS) that enables the segmentation of labrum and cartilage. 3D morphological parameters of the asymptomatic group will subsequently be compared with the 3D morphological parameters of patients with hip deformities, which were collected as part of a previous retrospective study.

Detailed Description

Hip deformities can cause hip pain and early onset osteoarthritis in young individuals.

Correcting these deformities typically involves planning with X-rays and MRI images, which offer a limited view of the hip joint's 3D structure. A comprehensive 3D analysis of hip structures, including cartilage, and labrum, would enhance diagnosis and surgery planning. However, 3D hip morphology hasn't been adequately described for distinguishing deformities.

The aim of this study is to describe normal 3D hip joint morphology in healthy participants and compare it to various hip joint deformities (Dysplasia, acetabular protrusion, retroversion, deep hip, and cam deformity).

Asymptomatic volunteers will undergo a non-contrast MRI of the hip at 3 Tesla using high-resolution morphologic 3D sequence (3D T2 DESS), which allows segmentation of labrum and cartilage.

The 3D morphological parameters of the asymptomatic group will then be compared with those of patients with hip deformities, data sourced from a retrospective study that included 100 patients from the outpatient clinic. These patients underwent direct MR arthrography at 3 Tesla in accordance with the institutional routine protocol at the Department of Diagnostic, Interventional, and Pediatric Radiology at Inselspital.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Individuals who are not considered suitable for MRI (Magnetic Resonance Imaging) for the following reasons:

  • Potential pregnancy
  • Presence of metal fragments in the eye or elsewhere in the body
  • Presence of implants and metallic foreign bodies, such as a pacemaker, heart valve, cerebrospinal fluid shunt, insulin pump, nerve stimulator, or cochlear implant
  • Claustrophobia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
cam DeformityMagnetic Resonance Imaging (MRI) of the hip with intra-articular contrast agentThis group is defined according to the following radiographic parameter: alpha angle \> 60°. The data was obtained from a retrospective study.
Asymptomatic volunteersNon- contrast Magnetic Resonance Imaging (MRI) of the hipHealthy individuals without history of hip pain or problems willing to undergo MRI of the hip.
Acetabular retroversionMagnetic Resonance Imaging (MRI) of the hip with intra-articular contrast agentThis group is defined according to the following radiographic parameters:positive posterior- wall- sign, positive ischial spine sign, and positive cross- over- sign. The data was obtained from a retrospective study.
Deep hipMagnetic Resonance Imaging (MRI) of the hip with intra-articular contrast agentThis group is defined according to the following radiographic parameter: LCE angle \> 39°. The data was obtained from a retrospective study.
Acetabular protrusionMagnetic Resonance Imaging (MRI) of the hip with intra-articular contrast agentThis group is defined according to the following radiographic parameter: positive protrusion sign. The data was obtained from a retrospective study.
Hip DysplasiaMagnetic Resonance Imaging (MRI) of the hip with intra-articular contrast agentThis group is defined according to the following radiographic parameter: lateral center edge angle (LCE) \< 23°. The data was obtained from a retrospective study.
Primary Outcome Measures
NameTimeMethod
Cartilage OrientationWithin 12 Months after MRI

Difference in hip cartilage orientation, measured in inclination (°) and anteversion (°), between healthy volunteers and patients with hip deformities.

Cartilage ThicknessWithin 12 Months after MRI

Difference in hip cartilage thickness (mm) between healthy volunteers and patients with hip deformities

Labrum LengthWithin 12 Months after MRI

Difference in labrum length (mm) between healthy subjects and patients with hip deformities.

Labrum AreaWithin 12 Months after MRI

Difference in hip labrum surface area (both absolute - mm² and relative - %) between healthy volunteers and patients with hip deformities.

Labrum VolumeWithin 12 Months after MRI

Difference in hip labrum volume (mm³) between healthy volunteers and patients with hip deformities.

Cartilage Surface AreaWithin 12 Months after MRI

Difference in hip cartilage surface area (both absolute - mm² and relative - %) between healthy volunteers and patients with hip deformities.

Cartilage VolumeWithin 12 Months after MRI

Difference in hip cartilage volume (mm³) between healthy volunteers and patients with hip deformities.

Secondary Outcome Measures
NameTimeMethod
iHOT 12 Questionnaireca. 5 minutes before MRI

The iHOT-12 is a validated questionnaire for young, active individuals with early hip disease. It covers four domains: symptoms and limitations, sports and recreation, job concerns, and social/emotional aspects. Responses are marked on a 100-mm scale, with the total score as a simple mean ranging from 0 to 100, where 100 represents the best possible quality of life.

Trial Locations

Locations (1)

University Hospital of Bern (Inselspital)

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath